Functional brain networks in the evaluation of patients with neurodegenerative disorders

[1]  D. Eidelberg,et al.  Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia , 2022, Human brain mapping.

[2]  V. Dhawan,et al.  Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's Disease , 2022, Movement disorders : official journal of the Movement Disorder Society.

[3]  Y. Guan,et al.  Consistent Abnormalities in Metabolic Patterns of Lewy Body Dementias , 2022, Movement disorders : official journal of the Movement Disorder Society.

[4]  D. Eidelberg,et al.  Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients , 2022, Scientific Reports.

[5]  D. Eidelberg,et al.  Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography , 2022, NeuroImage: Clinical.

[6]  K. Blennow,et al.  Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility , 2022, Nature Reviews Neurology.

[7]  D. Eidelberg,et al.  Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy. , 2022, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[8]  F. Agosta,et al.  Neuroimaging in Glucocerebrosidase‐Associated Parkinsonism: A Systematic Review , 2022, Movement disorders : official journal of the Movement Disorder Society.

[9]  V. Calhoun,et al.  A resting-state fMRI pattern of spinocerebellar ataxia type 3 and comparison with 18F-FDG PET , 2022, NeuroImage: Clinical.

[10]  D. Eidelberg,et al.  The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. , 2022, Cell metabolism.

[11]  P. Svenningsson,et al.  A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism , 2022, Scientific Reports.

[12]  J. O'Brien,et al.  Spatial covariance analysis of FDG-PET and HMPAO-SPECT for the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease , 2022, Psychiatry Research: Neuroimaging.

[13]  Lin F. Yang,et al.  Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet. Public health.

[14]  Michael C. Burkhart,et al.  Artificial intelligence for diagnosis and prognosis in neuroimaging for dementia; a systematic review , 2021, medRxiv.

[15]  R. Boellaard,et al.  EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  Danfeng Yu,et al.  Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019 , 2021, Frontiers in Public Health.

[17]  Ying Han,et al.  Exploring brain glucose metabolic patterns in cognitively normal adults at risk of Alzheimer’s disease: A cross-validation study with Chinese and ADNI cohorts , 2021, NeuroImage: Clinical.

[18]  M. Tittgemeyer,et al.  Dopaminergic pathways and resting-state functional connectivity in Parkinson’s disease with freezing of gait , 2021, NeuroImage: Clinical.

[19]  M. Modirrousta,et al.  Alzheimer’s Disease-Related Metabolic Pattern in Diverse Forms of Neurodegenerative Diseases , 2021, Diagnostics.

[20]  A. Drzezga,et al.  Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases , 2021, Science Translational Medicine.

[21]  V. Dhawan,et al.  Adaptive and pathological connectivity responses in Parkinson's disease brain networks. , 2021, Cerebral cortex.

[22]  R. Rodríguez-Labrada,et al.  Gene Therapy for Polyglutamine Spinocerebellar Ataxias: Advances, Challenges, and Perspectives , 2021, Movement disorders : official journal of the Movement Disorder Society.

[23]  W. Oertel,et al.  Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease , 2021, Molecular medicine.

[24]  D. Eidelberg,et al.  Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study , 2021 .

[25]  P. Cumming,et al.  Static versus Functional PET: Making Sense of Metabolic Connectivity. , 2021, Cerebral cortex.

[26]  O. Sporns,et al.  The human connectome in Alzheimer disease — relationship to biomarkers and genetics , 2021, Nature Reviews Neurology.

[27]  Alan C. Evans,et al.  Implication of metabolic and dopamine transporter PET in dementia with Lewy bodies , 2021, Scientific Reports.

[28]  D. Margulies,et al.  The default mode network in cognition: a topographical perspective , 2021, Nature Reviews Neuroscience.

[29]  D. Aarsland,et al.  Parkinson disease-associated cognitive impairment , 2021, Nature Reviews Disease Primers.

[30]  D. Eidelberg,et al.  Cognition-Related Functional Topographies in Parkinson's Disease: Localized Loss of the Ventral Default Mode Network. , 2021, Cerebral cortex.

[31]  Kan Cao,et al.  Gene targeting techniques for Huntington’s disease , 2021, Ageing Research Reviews.

[32]  O. Hansson.  Biomarkers for neurodegenerative diseases , 2021, Nature Medicine.

[33]  B. Jeon,et al.  Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder , 2021, Neurology.

[34]  David T. Jones,et al.  Alzheimer disease , 2021, Nature Reviews Disease Primers.

[35]  N. Brüggemann,et al.  Genotype-driven therapeutic developments in Parkinson’s disease , 2021, Molecular Medicine.

[36]  S. Hirano.  Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson’s disease , 2021, Molecular medicine.

[37]  V. Dhawan,et al.  Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[38]  V. Dhawan,et al.  Dynamic 18F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session , 2021, The Journal of Nuclear Medicine.

[39]  R. Boellaard,et al.  Feasibility of pharmacokinetic parametric PET images in scaled subprofile modelling using principal component analysis , 2021, NeuroImage: Clinical.

[40]  M. Tittgemeyer,et al.  The default mode network and cognition in Parkinson's disease: A multimodal resting‐state network approach , 2021, Human brain mapping.

[41]  I. Markaki,et al.  Novel targeted therapies for Parkinson’s disease , 2021, Molecular medicine.

[42]  Phillip G. D. Ward,et al.  Metabolic and Hemodynamic Resting-State Connectivity of the Human Brain: A High-Temporal Resolution Simultaneous BOLD-fMRI and FDG-fPET Multimodality Study. , 2021, Cerebral cortex.

[43]  M. Spillantini,et al.  Validation of the new pathology staging system for progressive supranuclear palsy , 2021, Acta Neuropathologica.

[44]  D. Eidelberg,et al.  Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration , 2021, Neurology.

[45]  Garam Lee,et al.  Alzheimer's disease drug development pipeline: 2021 , 2021, Alzheimer's & dementia.

[46]  K. Jellinger.  Pathobiological Subtypes of Alzheimer Disease , 2021, Dementia and Geriatric Cognitive Disorders.

[47]  Phoebe G. Spetsieris,et al.  Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson’s disease , 2020, NeuroImage.

[48]  L. Frings,et al.  Amyloid biomarkers as predictors of conversion from mild cognitive impairment to Alzheimer’s dementia: a comparison of methods , 2020, Alzheimer's research & therapy.

[49]  S. Kuwabara,et al.  The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease. , 2020, Journal of Alzheimer's disease : JAD.

[50]  L. Frings,et al.  Principal-Component Analysis–Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes , 2020, The Journal of Nuclear Medicine.

[51]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[52]  R. V. Kogan,et al.  Four‐Year Follow‐up of [18F]Fluorodeoxyglucose Positron Emission Tomography–Based Parkinson's Disease–Related Pattern Expression in 20 Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal Progression , 2020, Movement disorders : official journal of the Movement Disorder Society.

[53]  D. Eidelberg,et al.  Reproducible metabolic topographies associated with multiple system atrophy: Network and regional analyses in Chinese and American patient cohorts , 2020, NeuroImage: Clinical.

[54]  G. Fink,et al.  Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries. , 2020, Journal of Parkinson's disease.

[55]  M. Tittgemeyer,et al.  GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes , 2020, Movement disorders : official journal of the Movement Disorder Society.

[56]  R. V. Kogan,et al.  Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS‐PSP Criteria , 2020, Movement disorders : official journal of the Movement Disorder Society.

[57]  S. Stott,et al.  Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020 , 2020, Journal of Parkinson's disease.

[58]  Daniel Neil,et al.  Applications of machine learning to diagnosis and treatment of neurodegenerative diseases , 2020, Nature Reviews Neurology.

[59]  R. Helmich,et al.  Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease , 2020, Neurology.

[60]  Chris C. Tang,et al.  Atypical clinical presentation of pathologically proven Parkinson's disease: The role of Parkinson's disease related metabolic pattern. , 2020, Parkinsonism & related disorders.

[61]  Yilong Ma,et al.  Brain Functional and Structural Signatures in Parkinson’s Disease , 2020, Frontiers in Aging Neuroscience.

[62]  T. Montine,et al.  Arterial spin labeling detects perfusion patterns related to motor symptoms in Parkinson's disease. , 2020, Parkinsonism & related disorders.

[63]  John L. Robinson,et al.  Distribution patterns of tau pathology in progressive supranuclear palsy , 2020, Acta Neuropathologica.

[64]  Y. Guan,et al.  Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study , 2020, EJNMMI Research.

[65]  D. Eidelberg,et al.  Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns’ based approach , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[66]  M. Kameyama,et al.  Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease , 2020, Journal of Neurology.

[67]  Nick C Fox,et al.  Predicting sporadic Alzheimer’s disease progression via inherited Alzheimer’s disease-informed machine-learning , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[68]  Eric Westman,et al.  Biological subtypes of Alzheimer disease , 2020, Neurology.

[69]  Andrew B Singleton,et al.  The genetic architecture of Parkinson's disease , 2020, The Lancet Neurology.

[70]  E. Tolosa,et al.  LRRK2 in Parkinson disease: challenges of clinical trials , 2020, Nature Reviews Neurology.

[71]  Chris C. Tang,et al.  Metabolic Network Abnormalities in Drug‐Naïve Parkinson's Disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[72]  V. Dhawan,et al.  LRRK2 and GBA Variants Exert Distinct Influences on Parkinson's Disease-Specific Metabolic Networks. , 2019, Cerebral cortex.

[73]  J. Obeso,et al.  Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[74]  K. Ishii,et al.  Metabolic Network Topology of Alzheimer’s Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography , 2019, Journal of Alzheimer's disease : JAD.

[75]  Remco J. Renken,et al.  Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data , 2019, Int. J. Neural Syst..

[76]  G. Rücker,et al.  Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia , 2019, The Journal of Nuclear Medicine.

[77]  H. Shill,et al.  Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging. , 2019, Journal of neuropathology and experimental neurology.

[78]  Christos Davatzikos,et al.  Machine learning in neuroimaging: Progress and challenges , 2019, NeuroImage.

[79]  Tadashi Watabe,et al.  Evaluation of Functional Connectivity in the Brain Using Positron Emission Tomography: A Mini-Review , 2019, Front. Neurosci..

[80]  Matthias Reimold,et al.  Controls-based denoising, a new approach for medical image analysis, improves prediction of conversion to Alzheimer’s disease with FDG-PET , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[81]  Daniela Perani,et al.  Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography , 2019, Front. Neurosci..

[82]  Can-Xing Yuan,et al.  Metabolic pattern analysis of 18F-FDG PET as a marker for Parkinson’s disease: a systematic review and meta-analysis , 2019, Reviews in the neurosciences.

[83]  H. Jacobs,et al.  Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis. , 2019, Parkinsonism & related disorders.

[84]  Yu Kyeong Kim,et al.  A New Metabolic Network Correlated with Olfactory and Executive Dysfunctions in Idiopathic Rapid Eye Movement Sleep Behavior Disorder , 2019, Journal of clinical neurology.

[85]  Alan J. Thomas,et al.  Dementia with Lewy bodies: an update and outlook , 2019, Molecular Neurodegeneration.

[86]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[87]  J. O'Brien,et al.  Dementia with Lewy bodies — from scientific knowledge to clinical insights , 2018, Nature Reviews Neurology.

[88]  V. Dhawan,et al.  Gene therapy reduces Parkinson’s disease symptoms by reorganizing functional brain connectivity , 2018, Science Translational Medicine.

[89]  Gerta Rücker,et al.  Principal Components Analysis of Brain Metabolism Predicts Development of Alzheimer Dementia , 2018, The Journal of Nuclear Medicine.

[90]  Yoshihiro Kokubo,et al.  Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet Neurology.

[91]  C. Adler,et al.  Importance of low diagnostic Accuracy for early Parkinson's disease , 2018, Movement disorders : official journal of the Movement Disorder Society.

[92]  B. Bybel,et al.  Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia , 2018, Scientific Reports.

[93]  B. Bybel,et al.  Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia , 2018, Scientific Reports.

[94]  Remco J. Renken,et al.  The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease , 2018, The Journal of Nuclear Medicine.

[95]  Chris C. Tang,et al.  A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia , 2018, Alzheimer's & dementia.

[96]  H. Jacqmin-Gadda,et al.  Projections of prevalence, lifetime risk, and life expectancy of Parkinson's disease (2010‐2030) in France , 2018, Movement disorders : official journal of the Movement Disorder Society.

[97]  Stephen C. Strother,et al.  FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease , 2018, NeuroImage: Clinical.

[98]  Mario Quarantelli,et al.  Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity , 2018, NeuroImage.

[99]  D. Eidelberg,et al.  Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts , 2018, Human brain mapping.

[100]  Leonie Koban,et al.  Representation, Pattern Information, and Brain Signatures: From Neurons to Neuroimaging , 2018, Neuron.

[101]  D. Eidelberg,et al.  Network imaging biomarkers: insights and clinical applications in Parkinson's disease , 2018, The Lancet Neurology.

[102]  Olaf Sporns,et al.  Graph theory methods: applications in brain networks , 2018, Dialogues in clinical neuroscience.

[103]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[104]  Alzheimer’s Association.  2018 Alzheimer's disease facts and figures , 2018, Alzheimer's & Dementia.

[105]  K. Marder,et al.  Progression in the LRRK2-Asssociated Parkinson Disease Population , 2018, JAMA neurology.

[106]  Yue Huang,et al.  Reader response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium , 2018, Neurology.

[107]  Nick C Fox,et al.  Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference , 2017, bioRxiv.

[108]  Igor Yakushev,et al.  Metabolic connectivity: methods and applications , 2017, Current opinion in neurology.

[109]  Eyal Oren,et al.  Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, The Lancet. Neurology.

[110]  D. Eidelberg,et al.  Network Structure and Function in Parkinson’s Disease , 2017, Cerebral cortex.

[111]  Chris C. Tang,et al.  Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia. , 2017, JCI insight.

[112]  G. Rizzo,et al.  Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[113]  F. Nobili,et al.  The Alzheimer’s disease metabolic brain pattern in mild cognitive impairment , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[114]  Gerta Rücker,et al.  18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment , 2017, The Journal of Nuclear Medicine.

[115]  A. Willemsen,et al.  The cerebral metabolic topography of spinocerebellar ataxia type 3 , 2017, NeuroImage: Clinical.

[116]  D. Perani,et al.  Altered brain metabolic connectivity at multiscale level in early Parkinson’s disease , 2017, Scientific Reports.

[117]  John L. Robinson,et al.  Progression of alpha‐synuclein pathology in multiple system atrophy of the cerebellar type , 2017, Neuropathology and applied neurobiology.

[118]  Pierre Bellec,et al.  Resting-state network dysfunction in Alzheimer's disease: A systematic review and meta-analysis , 2017, Alzheimer's & dementia.

[119]  V. Dhawan,et al.  Abnormal metabolic brain network associated with Parkinson’s disease: replication on a new European sample , 2017, Neuroradiology.

[120]  E. Eskandar,et al.  Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. , 2017, JCI insight.

[121]  V. Calhoun,et al.  Resting-State Networks as Simultaneously Measured with Functional MRI and PET , 2017, The Journal of Nuclear Medicine.

[122]  Luke J. Chang,et al.  Building better biomarkers: brain models in translational neuroimaging , 2017, Nature Neuroscience.

[123]  A Jon Stoessl,et al.  Glucose utilization: still in the synapse , 2017, Nature Neuroscience.

[124]  Jack A. Wells,et al.  Volumetric Spatial Correlations of Neurovascular Coupling Studied using Single Pulse Opto-fMRI , 2017, Scientific Reports.

[125]  David Eidelberg,et al.  Parkinson's disease‐related network topographies characterized with resting state functional MRI , 2017, Human brain mapping.

[126]  D. Eidelberg,et al.  Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[127]  B. D. de Jong,et al.  Metabolic Imaging in Parkinson Disease , 2017, The Journal of Nuclear Medicine.

[128]  Chris C. Tang,et al.  Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases , 2016, Neurology.

[129]  M. Albert,et al.  Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. , 2016, JAMA neurology.

[130]  H. Berendse,et al.  Distribution and Load of Amyloid-&bgr; Pathology in Parkinson Disease and Dementia with Lewy Bodies , 2016, Journal of neuropathology and experimental neurology.

[131]  Chris C. Tang,et al.  Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia. , 2016, JCI insight.

[132]  Knut Engedal,et al.  Frontotemporal Dementia , 2016, Journal of geriatric psychiatry and neurology.

[133]  Jorge Cadima,et al.  Principal component analysis: a review and recent developments , 2016, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[134]  Shruti Agarwal,et al.  Neurovascular uncoupling in resting state fMRI demonstrated in patients with primary brain gliomas , 2016, Journal of magnetic resonance imaging : JMRI.

[135]  G. Rizzo,et al.  Accuracy of clinical diagnosis of Parkinson disease , 2016, Neurology.

[136]  Richard F. Betzel,et al.  Modular Brain Networks. , 2016, Annual review of psychology.

[137]  David Eidelberg,et al.  Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study , 2016, The Journal of Nuclear Medicine.

[138]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[139]  Jiaxiang Zheng,et al.  A FDG-PET Study of Metabolic Networks in Apolipoprotein E ε4 Allele Carriers , 2015, PloS one.

[140]  V. Dhawan,et al.  Abnormal Metabolic Pattern Associated with Cognitive Impairment in Parkinson'S Disease: A Validation Study , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[141]  R. Freeman,et al.  Neurometabolic coupling between neural activity, glucose, and lactate in activated visual cortex , 2015, Journal of neurochemistry.

[142]  D. Eidelberg,et al.  Assessing Cerebral Glucose Metabolism in Patients with Idiopathic Rapid Eye Movement Sleep Behavior Disorder , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[143]  Remco J. Renken,et al.  Classification of Parkinsonian Syndromes from FDG-PET Brain Data Using Decision Trees with SSM/PCA Features , 2015, Comput. Math. Methods Medicine.

[144]  Ji Hyun Ko,et al.  Metabolic resting-state brain networks in health and disease , 2015, Proceedings of the National Academy of Sciences.

[145]  M. Stamelou,et al.  Atypical parkinsonism: diagnosis and treatment. , 2015, Neurologic clinics.

[146]  E. Tolosa,et al.  Cognitive impairment and resting‐state network connectivity in Parkinson's disease , 2015, Human brain mapping.

[147]  D. Eidelberg,et al.  Effects of levodopa on regional cerebral metabolism and blood flow , 2015, Movement disorders : official journal of the Movement Disorder Society.

[148]  D. Eidelberg,et al.  Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder. , 2014, Brain : a journal of neurology.

[149]  S. Cappa,et al.  Brain connectivity in neurodegenerative diseases—from phenotype to proteinopathy , 2014, Nature Reviews Neurology.

[150]  Chris C. Tang,et al.  A disease-specific metabolic brain network associated with corticobasal degeneration. , 2014, Brain : a journal of neurology.

[151]  J. Roerdink,et al.  The Alzheimer's disease-related glucose metabolic brain pattern. , 2014, Current Alzheimer research.

[152]  C. Stam.  Modern network science of neurological disorders , 2014, Nature Reviews Neuroscience.

[153]  J. Joutsa,et al.  Diagnostic accuracy of parkinsonism syndromes by general neurologists. , 2014, Parkinsonism & related disorders.

[154]  Chris C. Tang,et al.  Network modulation following sham surgery in Parkinson's disease. , 2014, The Journal of clinical investigation.

[155]  H. Shill,et al.  Low clinical diagnostic accuracy of early vs advanced Parkinson disease , 2014, Neurology.

[156]  Brian Hansen,et al.  Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[157]  M. Chopp,et al.  Neurorestorative Therapy for Stroke , 2014, Front. Hum. Neurosci..

[158]  Jonathon Shlens,et al.  A Tutorial on Independent Component Analysis , 2014, ArXiv.

[159]  F. Hyder,et al.  Direct evidence for activity-dependent glucose phosphorylation in neurons with implications for the astrocyte-to-neuron lactate shuttle , 2014, Proceedings of the National Academy of Sciences.

[160]  V. Dhawan,et al.  Abnormal metabolic network activity in REM sleep behavior disorder , 2014, Neurology.

[161]  V. Dhawan,et al.  Quantifying Significance of Topographical Similarities of Disease-Related Brain Metabolic Patterns , 2014, PloS one.

[162]  Massimo Filippi,et al.  Functional network connectivity in the behavioral variant of frontotemporal dementia , 2013, Cortex.

[163]  David Eidelberg,et al.  Metabolic network as a progression biomarker of premanifest Huntington's disease. , 2013, The Journal of clinical investigation.

[164]  Massimo Filippi,et al.  Brain network connectivity assessed using graph theory in frontotemporal dementia , 2013, Neurology.

[165]  Y. Guan,et al.  Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging. , 2013, Parkinsonism & related disorders.

[166]  J. Roerdink,et al.  Validation of parkinsonian disease‐related metabolic brain patterns , 2013, Movement disorders : official journal of the Movement Disorder Society.

[167]  Aapo Hyvärinen,et al.  Independent component analysis: recent advances , 2013, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[168]  David Eidelberg,et al.  Metabolic brain networks in translational neurology: Concepts and applications , 2012, Annals of neurology.

[169]  Chris C. Tang,et al.  Network correlates of disease severity in multiple system atrophy , 2012, Neurology.

[170]  W. Kukull,et al.  Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 , 2012, Journal of neuropathology and experimental neurology.

[171]  M. Weiner,et al.  A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.

[172]  M. Hallett,et al.  Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? , 2012, Brain : a journal of neurology.

[173]  Chris C. Tang,et al.  Improved Sequence Learning with Subthalamic Nucleus Deep Brain Stimulation: Evidence for Treatment-Specific Network Modulation , 2012, The Journal of Neuroscience.

[174]  G. Frisoni,et al.  Functional network disruption in the degenerative dementias , 2011, The Lancet Neurology.

[175]  V. Dhawan,et al.  Network correlates of the cognitive response to levodopa in Parkinson disease , 2011, Neurology.

[176]  Richard Watts,et al.  Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. , 2011, Brain : a journal of neurology.

[177]  David Eidelberg,et al.  Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues , 2011, NeuroImage.

[178]  Angelo Antonini,et al.  Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects , 2011, NeuroImage.

[179]  Thomas Wichmann,et al.  Extrastriatal Dopaminergic Circuits of the Basal Ganglia , 2010, Front. Neuroanat..

[180]  Yaakov Stern,et al.  Multivariate Data Analysis for Neuroimaging Data: Overview and Application to Alzheimer’s Disease , 2010, Cell Biochemistry and Biophysics.

[181]  Mark Newman,et al.  Networks: An Introduction , 2010 .

[182]  H. Braak,et al.  A timeline for Parkinson's disease. , 2010, Parkinsonism & related disorders.

[183]  Chris C. Tang,et al.  Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis , 2010, The Lancet Neurology.

[184]  Chris C. Tang,et al.  Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease , 2010, The Journal of Neuroscience.

[185]  D. Alsop,et al.  Parkinson's Disease Spatial Covariance Pattern: Noninvasive Quantification with Perfusion MRI , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[186]  D. Eidelberg.  Metabolic brain networks in neurodegenerative disorders: a functional imaging approach , 2009, Trends in Neurosciences.

[187]  Andreas Daffertshofer,et al.  Functional similarities and distance properties , 2009, Journal of Neuroscience Methods.

[188]  Santo Fortunato,et al.  Community detection in graphs , 2009, ArXiv.

[189]  David Eidelberg,et al.  Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features , 2009, NeuroImage.

[190]  Vince D. Calhoun,et al.  A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data , 2009, NeuroImage.

[191]  David Eidelberg,et al.  Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. , 2008, Brain : a journal of neurology.

[192]  David Eidelberg,et al.  Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease , 2008, The Journal of Neuroscience.

[193]  V. Dhawan,et al.  Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease , 2008, Neurology.

[194]  D. Eidelberg,et al.  Abnormal metabolic networks in atypical parkinsonism , 2008, Movement disorders : official journal of the Movement Disorder Society.

[195]  V. Dhawan,et al.  Changes in network activity with the progression of Parkinson's disease. , 2007, Brain : a journal of neurology.

[196]  David Eidelberg,et al.  Functional Imaging of Cerebral Blood Flow and Glucose Metabolism in Parkinson’s Disease and Huntington’s Disease , 2007, Molecular Imaging and Biology.

[197]  V. Dhawan,et al.  Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[198]  David Eidelberg,et al.  Metabolic brain networks associated with cognitive function in Parkinson's disease , 2007, NeuroImage.

[199]  V. Dhawan,et al.  Network modulation in the treatment of Parkinson's disease. , 2006, Brain : a journal of neurology.

[200]  Yaakov Stern,et al.  PET Network Abnormalities and Cognitive Decline in Patients with Mild Cognitive Impairment , 2006, Neuropsychopharmacology.

[201]  Anna Barnes,et al.  Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease , 2006, NeuroImage.

[202]  Anna Barnes,et al.  FDG PET in the differential diagnosis of parkinsonian disorders , 2005, NeuroImage.

[203]  Yaakov Stern,et al.  A New Approach to Spatial Covariance Modeling of Functional Brain Imaging Data: Ordinal Trend Analysis , 2005, Neural Computation.

[204]  Yaakov Stern,et al.  Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance , 2004, NeuroImage.

[205]  Lee M. Miller,et al.  Measuring interregional functional connectivity using coherence and partial coherence analyses of fMRI data , 2004, NeuroImage.

[206]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[207]  K. Worsley,et al.  The geometry of correlation fields with an application to functional connectivity of the brain , 1999 .

[208]  OUP accepted manuscript , 2022, Cerebral Cortex.

[209]  Ambra Stefani,et al.  Idiopathic REM sleep behaviour disorder and neurodegeneration — an update , 2018, Nature Reviews Neurology.

[210]  Kwan-Liu Ma,et al.  Visual Reasoning about Social Networks Using Centrality Sensitivity , 2012, IEEE Transactions on Visualization and Computer Graphics.

[211]  G. Alexander,et al.  Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: A principal component approach to modeling brain function in disease , 1994 .